Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019.
Rossetti B, Paglicci L, Di Maio VC, Cassol C, Barbaliscia S, Paolucci S, Bruzzone B, Coppola N, Montagnani F, Micheli V, Monno L, Zanelli G, Santantonio T, Cuomo N, Caudai C, Zazzi M, Ceccherini-Silberstein F, On Behalf Of The Hcv Virology Italian Resistance Network Vironet C.
Rossetti B, et al. Among authors: zazzi m.
Infez Med. 2021 Jun 1;29(2):242-251.
Infez Med. 2021.
PMID: 34061790
Free article.